AspirinAsthmaPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalTiclopidineThromboxane B2Cyclooxygenase InhibitorsPlatelet AggregationAnti-Asthmatic AgentsSalicylatesPlatelet Function TestsDrug Therapy, CombinationAsthma, Aspirin-InducedBlood PlateletsSodium SalicylateFibrinolytic AgentsAsthma, Exercise-InducedHemorrhageDouble-Blind MethodAnticoagulantsWarfarinTablets, Enteric-CoatedRisk FactorsCyclooxygenase 1Dose-Response Relationship, DrugBleeding TimeGastrointestinal HemorrhageProstaglandin-Endoperoxide SynthasesPlatelet ActivationAdministration, InhalationThromboxanesPeak Expiratory Flow RateIbuprofenThromboxane A2Treatment OutcomeForced Expiratory VolumeThrombosisAsthma, OccupationalCyclooxygenase 2 InhibitorsProspective StudiesDipyridamoleAcetaminophenBronchial HyperreactivityLipoxinsBronchodilator AgentsRespiratory SoundsDrug ResistanceTime FactorsAdrenal Cortex HormonesAllergensIndomethacinRhinitisMyocardial InfarctionSulfinpyrazoneGastric MucosaHypersensitivityCyclooxygenase 2Drug HypersensitivityStrokeFollow-Up StudiesReye SyndromeProstaglandinsStomach UlcerPrimary PreventionNaproxen